Coronavirus (COVID-19) updates for UC San Diego Health patients and visitors. Learn More

Menu
Search

Roger Tsien Receives Neurosciences Prize

 

September 21, 2005  |  

The University of North Carolina (UNC) at Chapel Hill has named Roger Tsien, Ph.D., University of California, San Diego (UCSD) professor of pharmacology, chemistry and biochemistry, the recipient of the fifth annual Perl-UNC Neuroscience Prize.

The prize carries a $10,000 award and is given to recognize a seminal achievement in neuroscience. Tsien was recognized for developing molecular indicators that have revolutionized the optical monitoring of neurons. He has developed a wide variety of tools for optically monitoring the structure and function of cells and molecules in the nervous system, including calcium indicator dyes, genetically coded protein biosensors and modifications to green fluorescent protein, GFP. These tools have made it possible for scientists to visualize signaling processes in nerve cells both in cell culture and in the brains of living animals.

Tsien, a Howard Hughes Medical Institute investigator, is a member of the Institute of Medicine, which advises the nation on improving health, and the National Academy of Sciences. His laboratory's goal is to gain a better understanding of signaling inside individual living cells, in neuronal networks and in tumors,. His team designs, synthesizes and uses new molecules that detect or manipulate biochemical signals.

Previous recipients of the prize are Dr. David Julius of the University of California at San Francisco; Dr. Roderick MacKinnon of Rockefeller University; co-recipients Dr. Linda Buck of the Fred Hutchinson Cancer Research Center in Seattle and Dr. Richard Axel of Columbia University; and, last years recipient, Dr. Yves Barde of the Biocenter at the University of Basel in Switzerland.

News Media Contact:

Sue Pondrom, 619-543-6163, spondrom@ucsd.edu




Media Contact

Share This Article


Related News

5/26/2020
UC San Diego Health has deployed a mobile ECMO life support system to help sustain critically-ill patients during the pandemic.
5/21/2020
During COVID-19, UC San Diego Health expanded telehealth to provide patients with safe and convenient access to appointments with their health care providers. Video visits expanded by more than 50-fol ...
5/19/2020
UC San Diego researchers have identified small molecules in the blood of asymptomatic pregnant women that may predict risk for preeclampsia, responsible for a significant proportion of maternal and ne ...
5/15/2020
The NIH has launched a major clinical trial to assess the malaria drug hydroxychloroquine and antibiotic azithromycin as a treatment for COVID-19. The trial will recruit 2,000 participants at 30 sites ...



Follow Us